Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Cancer Vaccines01:30

Cancer Vaccines

340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colloidal Dispersions of Gramicidin D in Water: Preparation, Characterization, and Differential Cytotoxicity.

ACS omega·2025
Same author

The Role of Dendritic Cells in Adaptive Immune Response Induced by OVA/PDDA Nanoparticles.

Vaccines·2025
Same author

Transient Coatings from Nanoparticles Achieving Broad-Spectrum and High Antimicrobial Performance.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Characterization and Differential Cytotoxicity of Gramicidin Nanoparticles Combined with Cationic Polymer or Lipid Bilayer.

Pharmaceutics·2022
Same author

Supramolecular Nanostructures for Vaccines.

Biomimetics (Basel, Switzerland)·2022
Same author

Cationic and Biocompatible Polymer/Lipid Nanoparticles as Immunoadjuvants.

Pharmaceutics·2021

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

587

Emerging Cationic Nanovaccines.

Ana Maria Carmona-Ribeiro1, Yunys Pérez-Betancourt2

  • 1Biocolloids Laboratory, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil.

Pharmaceutics
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

Cationic nanovaccines deliver antigens to immune cells, enhancing defense against infections and cancer. Careful formulation minimizes toxicity, enabling effective immune responses and potential cancer immunotherapy.

Keywords:
cationic lipids and polymersimmunological cell deathimmunotherapiesnanoadjuvantsnanoparticles from self-assemblynanovaccines against cancernanovaccines against infectious diseases

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

587
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Area of Science:

  • Nanotechnology
  • Immunology
  • Vaccinology

Background:

  • Cationic nanovaccines facilitate direct delivery of antigens and immunomodulators to dendritic cells in lymph nodes.
  • These positively charged nanovaccines are uptaken by antigen-presenting cells (APCs), initiating immune responses against intracellular infections and cancers.
  • Cationic molecules in nanovaccines offer protection against nucleic acid degradation but can exhibit dose-dependent toxicity.

Purpose of the Study:

  • To explore the potential of cationic nanovaccines in delivering antigens and immunomodulators.
  • To address the dose-dependent toxicity associated with cationic molecules in nanovaccine formulations.
  • To investigate the application of cationic nanovaccines in combating infections and cancer.

Main Methods:

  • Formulation of nanometric-sized cationic vaccines for direct antigen and immunomodulator delivery.
  • Utilizing antigen-presenting cells (APCs) for initiating cellular immunological defense.
  • Investigating strategies to mitigate cationic molecule toxicity, including dilution in biocompatible polymeric matrixes.
  • Developing in situ designs for cationic nanovaccines in cancer vaccinology.

Main Results:

  • Cationic nanovaccines effectively elicit a Th 1 immune response below toxicity thresholds.
  • Dilution of cationic components in polymeric matrices reduces or eliminates toxic effects.
  • mRNA cationic nanovaccines have rapidly advanced, particularly against coronavirus.
  • Cationic nanovaccines show promise for in situ cancer vaccine design and immunotherapy.

Conclusions:

  • Cationic nanovaccines are effective delivery systems for antigens and immunomodulators, crucial for fighting infections and cancer.
  • Managing cationic molecule concentration and employing strategies like polymeric matrices are key to ensuring safety and efficacy.
  • The development of cationic nanovaccines represents a significant advancement in vaccinology, with broad applications in infectious disease prevention and cancer treatment.